Quick Job Search
Enter Keyword(s):
Enter a City:  

Select a State:

Select a Category:


  - Advanced Job Search
  - Search by Category

Pharma-Industry News

 
Get A 700+ Credit Score - Sponsored Link
Former Keys jail guard gets 16 years: Hernandez sentenced for drug conspiracy
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Kingdom OKs Glaxo vaccine
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Quintiles Announces Clinical Pharmacology Alliance with AstraZeneca
UT Southwestern Researchers Use Drug-Radiation Combo to Eradicate Lung Cancer
Aureus Pharma Extends its Knowledge Database Agreement with Sanofi-Aventis R&D
Pharma Outsourcing, 8-9 April 2010, Munich, Germany
Impedance-Based Measurement of GPCR Modulators in Drug Discovery â€" Characterization of Signalling Pathways in Recombinant and Non-Recombinant Cells
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Biopharmaceutical Companies Generating Gains: ZGEN, INO - sourced PicksThatMove.com
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
The creation of a new niche specialty pharmaceutical company focused on rare diseases - with ...
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Virginia Man Sues Walmart and Drug Company Over 2-Day Erection
Pharma companies deny reports on spurious drugs
Elan, Biogen change Tysabri
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Johnson & Johnson to cut 7,000 jobs
Johnson & Johnson-Shampoo-Baby Shampoo (detangling formula) (3.9 lippies, 12 reviews)
GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
RXi Pharmaceuticals Appoints Noah D. Beerman as CEO
Plethico Pharmaceuticals introduces new Natrol 'Immune Boost'
China Pharma Holdings Inc. (NYSE AMEX:CPHI) to Release Q3 2009 Earnings November 12
Hemispherx Biopharma Announce Two Prong Chronic Fatigue System Mission
Helix Biopharma Finish 120 Patient Enrollment for Phase II Trial of Topical Interferon Alpha-2b for Treatment of Ano-Genital Warts
GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
Is Your Doctor’s Continuing Ed Funded by Pharma?